Join to View Full Profile
22 S Greene StBaltimore, MD 21201
Phone+1 410-328-2549
Fax+1 410-328-0697
Dr. Ahmad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Haroon Ahmad is a neuro-oncologist based in Baltimore, MD, with an impressive educational background. He completed his undergraduate studies at the University of Maryland, BC and pursued a Medical Degree at the University of Virginia School of Medicine. Furthering his specialization, he completed a residency and a chief residency in Neurology at Rutgers Health/Robert Wood Johnson Medical School, and a Fellowship in Neuro-Oncology at the University of Virginia Medical Center. Currently, he serves as an Assistant Professor at the University of Maryland Medical Center. A cited author in numerous publications, Dr. Ahmad has substantial contributions to the field, particularly on novel therapeutics in the treatment of gliomas.
Education & Training
University of Virginia Medical CenterFellowship, Hematology and Medical Oncology, 2017 - 2019
Rutgers Health/Robert Wood Johnson Medical SchoolChief Residency, Neurology, 2016 - 2017- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Neurology, 2013 - 2017
ECU Health Medical Center/East Carolina UniversityInternship, Internal Medicine, 2013 - 2014
University of Virginia School of MedicineClass of 2012, MD
Certifications & Licensure
MD State Medical License 2019 - 2026
VA State Medical License 2017 - 2024
NJ State Medical License 2014 - 2018
NC State Medical License 2013 - 2014
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Baltimore Top Doctor Baltimore Magazine, 2024
Publications & Presentations
PubMed
- CNS infiltration by zamtocabtagene autoleucel tandem CD20/CD19 CAR T cells leading to complete remission in a patient with primary CNS lymphoma.Nancy M Hardy, Jean A Yared, Tim Luetkens, Haroon Ahmad, Rediet Mulatu
Haematologica. 2026-04-01 - Correction: Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.Ali M Saeed, Søren M Bentzen, Haroon Ahmad, Lily Pham, Graeme F Woodworth
Radiation Oncology. 2024-05-15 - 3 citationsSystematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.Ali M Saeed, Søren M Bentzen, Haroon Ahmad, Lily Pham, Graeme F Woodworth
Radiation Oncology. 2024-03-14
Press Mentions
Clinical Trial Aids Chestertown Man in Beating Aggressive CancerMarch 1st, 2023- Air Pollution May Directly Increase Alzheimer's Risk, Study FindsFebruary 24th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
